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Abstract. The role of the simian virus 5 (SV5) fusion 
(F) protein 20 residue COOH-terminal region, thought 
to represent the cytoplasmic tail, in fusion activity was 
examined by constructing a series of COOH-terminal 
truncation mutants. When the altered F proteins were 
expressed in eukaryotic cells, by using the vaccinia vi- 
rus-T7 transient expression system, all the F proteins 
exhibited similar intracellular transport properties and 
all were expressed abundantly on the cell surface. 
Quantitative and qualitative cell fusion assays indicated 
that all of the F protein COOH-terminal truncation 
mutants mediated lipid mixing with similar kinetics and 
efficiency as that of wild-type F protein. However, the 
cytoplasmic content mixing activity decreased in paral- 
lel with the extent of the deletion in the F protein 
COOH-terminal truncation mutants. These data indi- 
cate that it is possible to separate the presumptive early 
step in the fusion reaction, hemifusion, and the final 
stage of fusion, content mixing, and that the presence of 
the F protein COOH-terminal region is important for 
the final steps of fusion. 
M 
EMBRANE fusion is an essential biochemical pro- 
cess critical for intracellular membrane traffick- 
ing, fertilization, and synaptic transmission. En- 
veloped virus-induced  fusion  has  been  one  of the  best 
characterized membrane fusion reactions. The entry of en- 
veloped viruses into cells occur by fusion of the viral mem- 
brane with either the host cell plasma membrane or with 
the membrane of an endocytic vesicle. With many envel- 
oped viruses, membrane fusion is induced by a fusogenic 
spike  glycoprotein which  is  also  responsible  for  attach- 
ment of viral particles to the target cell. With the paramyx- 
oviruses, however, the functions of attachment and fusion 
are mediated by two different spike glycoproteins (Scheid 
et al., 1972; for review see Stegmann et al., 1989; White, 1990). 
Simian virus 5 (SV5) ~ is a member of the family para- 
myxoviridae and  contains  two integral  membrane  spike 
glycoproteins,  the  hemagglutinin-neuraminidase  protein 
(HN), and the fusion protein (F) (Paterson et al.,  1984b, 
1985; Scheid et al., 1972; Scheid and Choppin, 1974). The 
HN protein provides the attachment function allowing the 
virus particle to bind to sialic acid containing receptors on 
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the cell surface, whereas the F protein is directly involved 
in virus-induced membrane fusion. The F protein is a type 
I integral membrane protein and computer-assisted analy- 
sis indicates that it contains a 484-residue ectodomain, a 
25-residue transmembrane domain, and a 20-residue cy- 
toplasmic tail (Paterson et al.,  1984b, Lamb,  1993).  It is 
synthesized as an inactive precursor (F0) which is cleaved 
by a cellular protease in the trans-Golgi apparatus (Klenk 
and Garten, 1994; Scheid and Choppin, 1974) to form the 
biologically  active  protein  consisting  of  the  disulfide 
linked chains F t and F 2. 
It has become increasingly clear that there is a  differ- 
ence  in  the  requirements  for  fusion  among  different 
paramyxoviruses (Bagai and Lamb, 1995b; Horvath et al., 
1992).  Whereas most of the paramyxoviruses require the 
coexpression of homotypic F and HN proteins in order to 
induce cell-cell fusion (Ebata et al., 1991; Hu et al., 1992; 
Morrison et al., 1991; Sergel et al., 1993; Tanabayashi et al., 
1992; Wild et al., 1991), a homotypic HN protein is not es- 
sential for SV5 F protein-mediated cell fusion (Bagai and 
Lamb, 1995b). Further evidence for the sufficiency of SV5 
F protein in cell fusion comes from the finding that F mu- 
tants  containing single  Gly to Ala changes in the fusion 
peptide cause a remarkable increase in the syncytia forma- 
tion compared to the wild-type (wt) F  protein (Horvath 
and  Lamb,  1992;  Ward  et al.,  1995). To understand  the 
mechanism of F  protein-induced membrane fusion, it is 
important to understand the role of different domains of 
the F protein in mediating fusion. While it is known that 
the  fusion  peptide  and  adjacent  heptad  repeat  regions 
have important roles in fusion (Horvath and Lamb, 1992; 
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the cytoplasmic tail of the F proteins is less clear. Studies 
with human immunodeficiency virus type 2 and simian im- 
munodeficiency virus envelope glycoproteins (env) have 
shown  that  cytoplasmic  tail  truncation  mutants  signifi- 
cantly enhance syncytia formation and alter the conforma- 
tion of the external domain of env (Mulligan et al., 1992; 
Ritter et al., 1993). For the paramyxoviruses, examination 
of the role of the F protein cytoplasmic tail in fusion has 
led to disparate results: for Newcastle disease virus, F pro- 
tein  cytoplasmic  tail  deletions  greatly  reduced  syncytia 
formation (Sergel and Morrison, 1995), for human parain- 
fluenza virus type 3, the F protein cytoplasmic tail mutants 
showed reduced cell surface expression due to a defect in 
oligomerization, and for human parainfluenza virus type 2, 
F  protein cytoplasmic tail deletions did not affect fusion 
(Yao and Compans, 1995).  However, in all of these stud- 
ies, the effect of mutations in the cytoplasmic tail on the fi- 
nal extent of fusion was examined and the early steps in fu- 
sion were not investigated. 
Recent  studies  with  a  glycosyl  phosphatidyl  inositol 
(GPI)-linked form of influenza virus hemagglutinin (HA), 
where the HA lacks its normal transmembrane and cyto- 
plasmic domains,  have shown  that  GPI-anchored HA is 
competent in mediating fusion of the outer leaflets of the 
lipid bilayer (hemifusion) but there was no mixing of the 
aqueous contents (content mixing) (Kemble et al.,  1994; 
Melikyan et al.,  1995). It has been suggested for influenza 
virus HA that separate domains of HA may control indi- 
vidual steps in fusion (Kemble et al., 1994; Melikyan et al., 
1995). The present study was undertaken to define the re- 
quirement of the cytoplasmic domain of the SV5 F protein 
in  the  membrane fusion process, using quantitative  bio- 
physical assays to measure the kinetics of membrane fusion 
and the extent of content mixing and employing qualita- 
tive fluorescence measurements to follow the movement 
of membrane and aqueous dyes. The results indicate that 
hemifusion but not complete fusion occurs in the absence 
of the cytoplasmic domain of the SV5 F protein. We inter- 
pret these data to indicate that hemifusion is an intermediate 
step common to virus-mediated membrane protein fusion. 
Materials and Methods 
Cells and Recombinant Plasmid Vectors 
Monolayer cultures of the TC7 subclone of CV-1 cells and HeLa-T4 cells 
were grown in Dulbecco's modified Eagle's medium (DMEM) containing 
10% NU Serum IV (Collaborative Research Laboratories, Inc., Bedford, 
MA) as described previously (Paterson et al., 1985). 
The SV5 F and HN cDNAs described previously (Horvath et al., 1992; 
Paterson et al., 1984a, b) were subcloned into pGEM2X, a derivative of 
pGEM2 containing an XhoI site (Bagai and Lamb, 1995b).  The plasmid 
pTF7.5 containing the hemagglutinin (HA) cDNA of influenza virus A/ 
Udorn/72 was described previously (Simpson and Lamb, 1992). The plas- 
mid pGINT7 13-gal (Nussbaum et al., 1994) containing the [3-galactosidase 
cDNA was kindly provided by Drs. Edward  Berger and Bernard Moss 
(National  Institutes of Health,  Bethesda,  MD).  All  the  cDNAs  were 
cloned in pGEM2X in an orientation such that mRNA-sense RNA tran- 
scripts could be synthesized by using bacteriophage T7 RNA polymerase. 
Oligonucleotide-directed Mutagenesis and Generation 
ofF Protein COOH-Terminal Truncation Mutants 
pGEM2X-F was used as the template for mutagenesis. Clones encoding 
the SV5 F protein COOH-terminal truncation mutants A5, A10, A15, and 
A19 were constructed by oligonucleotide-directed unique site elimination 
(U.S.E)  mutagenesis (Deng and Nickoloff, 1992)  by introducing prema- 
ture translational stop codons into the coding sequence to obtain COOH- 
terminal deletions of 5, 10, 15, and 19 residues, respectively. In addition to 
the COOH-terminal truncation mutants, a revertant BWT (back wt) was 
also constructed by replacing the translational stop codon in mutant A19 
with the codon for leucine. U.S.E mutagenesis was performed using the 
U.S.E.  TM mutagenesis kit following the instructions of the supplier (Phar- 
macia Biotech, Inc., Piscataway, N J). 
Oligonucleotides  were  synthesized by  the  Northwestern  University 
Biotechnology Facility on a DNA synthesizer (model 380B, Applied Bio- 
systems, Inc. Foster City, CA). The nucleotide sequence of the F protein 
COOH-terminal  truncation  mutants was  determined  by  dideoxynucle- 
otide chain-terminating sequencing (Sanger et al., 1977). 
Expression ofF Protein COOH-Terminal Truncation 
Mutants and Metabolic Labeling of Cells 
The mutant F proteins were expressed by using the vaccinia virus-bacte- 
riophage T7 RNA polymerase transient expression system (Fuerst et al., 
1986).  Subcontinent monolayers of HeLa-T4 or CV-1 cells were infected 
with recombinant vaccinia virus vTF7-3 at a multiplicity of infection of l0 
pfu/cell and incubated at 37°C for 45 min. The virus inoculum was re- 
moved and cells were transfected with wt and mutant plasmid DNA using 
cationic liposomes made in our laboratory as described previously (Rose 
et al., 1991).  Transfection was done according to the protocol  for using 
TransfectACE  TM  (GIBCO  BRL,  Gaithersburg, MD)  essentially as de- 
scribed (Rose et al., 1991). Typically 2.5 ~g of plasmid DNA was used for 
a 35-mm tissue culture dish and the volume was adjusted to 0.5 ml with 
OPTI-MEM (GIBCO BRL). At 5 h  posttransfection, cells were washed 
twice  in phosphate-buffered saline and  incubated in cysteine- and  me- 
thionine-deficient DMEM  (DMEM  Cys- Met-)  for 30 min. For pulse- 
chase experiments, cells were labeled with Tran-ass-label (100 ~Ci per ml) 
(ICN Radiochemicals, Irvine, CA) in DMEM Cys- Met- for the pulse pe- 
riod indicated. The chase period was initiated by removal of the labeling 
medium, the cells were washed with prewarmed chase medium (DMEM 
supplemented with 2 mM unlabeled cysteine and methionine and 2% NU 
serum IV), and then additional chase medium was added. The cells were 
then incubated for varying periods after which they were lysed in ice-cold 
RIPA buffer containing protease inhibitors (Paterson and Lamb, 1987) 
and 25 mM iodoacetamide. 
Chemical Cross-Linking 
HeLa-T4 cells expressing the SV5 wt F and COOH-terminal truncation 
mutant proteins were  labeled  with  Tran-aSS-label  (100  IxCi per  ml) in 
DMEM Cys- Met  for 30 min at 5 h posttransfection and incubated in 
chase medium for 2 h. Chemical cross-linking analysis was performed as 
described previously (Russell et al., 1994)  using the cross-linking reagent 
3,3'-dithiobis(sulfosuccinirnidyl propionate)  (DTSSP)  (Pierce  Chemical 
Co., Rockford, IL). 
Immunoprecipitation, SDS-PAGE, and Quantification 
of  Autoradiograms 
F proteins were immunoprecipitated from cell lysates by using a rabbit an- 
tiserum raised against a mixture of three synthetic peptides specific for F2 
residues 22 to 39, 31 to 46, and 77 to 94 (Horvath and Lamb, 1992). Immu- 
noprecipitation  was  performed  as  described  previously  (Lamb  et  al., 
1978). Polypeptides were analyzed by SDS-PAGE. Cross-linked polypep- 
tides were analyzed on 3.5% acrylamide gels (Gething et al., 1989; Russell 
et al., 1994),  nonreduced F polypeptides on 10% acrylamide gels and re- 
duced F  polypeptides on 15%  acrylamide gels, and gels were processed 
for  fluorography  as  described  previously  (Lamb  and  Choppin,  1976; 
Paterson and Lamb, 1993). Autoradiograms were quantified by using a la- 
ser densitometer (LKB Ultrascan; Pharmacia-LKB, Inc., Piscataway, N J) 
equipped with LKB Gelscan SL software. 
Endo-fl-N-acetylglucosaminidase Digestions 
To  test  for  the conversion of N-linked carbohydrate  chains from high 
mannose to the complex form, immune complexes were digested with 1 mU 
of endoq3-N-acetylglucosaminidase (endo H) (Boehringer-Mannheim Bio- 
chemicals, Indianapolis, IN) as described previously (Ng et al., 1989). Pep- 
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ments were done as described previously (Melikyan et al., 1995; Paterson 
and Lamb, 1993). 
Quantification of Surface Expression: FA CS Analysis 
For flow cytometry, HeLa-T4 cells were grown on culture dishes (6 cm) to 
70%  confluence.  At  5  h  posttransfection, cells  were chilled  on  ice  and 
treated for flow cytometric analysis as described previously (Horvath and 
Lamb, 1992) using monoelonal antibody F1 a specific for the SV5 F glyco- 
protein  (Randall  et  al.,  1987) as the  primary antibody and  fluorescein 
isothiocyanate--conjugated goat  anti-mouse IgG as the  secondary anti- 
body.  Fluorescence intensity of  10,000 cells  was measured by a  FAC- 
SCAN flow cytometer (Becton Dickinson, Mountain View, CA). 
Incorporation of Fluorescent Probes into Erythrocytes 
Fresh human red blood cells  (RBCs) were labeled either singly  or cola- 
beled with membrane and aqueous dyes. Labeling of RBCs with the lipid 
probe octadecyl  rhodamine B  (R18) was carried out as described previ- 
ously (Bagai and Lamb, 1995b).  Entrapment of the aqueous dye NBD- 
taurine was done as described previously (Sarkar et al., 1989). RBCs were 
colabeled with R18 and NBD-taurine by injecting 15 ~l of 1 mg/ml R18 
in ethanol to the RBCs suspended in 10 mM NBD-taurine in PBS at 37°C 
as described (Sarkar et al., 1989). After labeling,  the RBC suspension was 
washed six times with 50 ml PBS to remove the unincorporated RI8 and 
NBD-taurine. The double-loaded erythrocytes could be stored for 2-3 d 
without significant leakage  of dyes. RBCs were loaded with either the fluo- 
rescent aqueous dye  ethidium bromide (EtBr) or HOECHST 33258  by 
mild  hypotonic lysis as described previously (Ellens et al.,  1989). The 
hypotonic solution contained either i mM ethidium bromide or HOECHST 
33258 in 10 mM Tris-HCl, 0.5 mM EGTA, pH 7.5. More than 90%  of the 
cells trapped the dyes. 
Binding and Fusion of Loaded RBCs 
with Cells Expressing Viral Envelope Proteins: 
Fluorescence Microscopy 
CV-1 cells grown on coverslips and expressing wt or mutant F and wt HN 
proteins at 5 h posttransfection were washed twice  and incubated over- 
night at 32°C in DMEM containing 10%  NU serum IV. The cells  were 
washed  with  PBS,  incubated  for  1  h  at  37°C  with  50  mU  per  ml  of 
neuraminidase  (Vibrio  cholerae)  (Boehringer Mannheim,  Indianapolis, 
IN) in DMEM and washed twice  with PBS.  3  ml of (co)labeled  RBCs 
(0.1%  hematocrit) in PBS were added to the monolayer and incubated at 
4°C for 30 rain with occasional gentle agitation,  Unbound RBCs were re- 
moved by six washes with PBS.  Fusion was triggered by transferring the 
coverslips to  37°C  for  varying  time  periods  and  coverslips were  then 
placed on microscope slides  and cells photographed with a Nikon Micro- 
phot FXA microscope system (Nikon Corp., Tokyo, Japan). NBD fluores- 
cence was visualized  under a "fluorescein" filter set,  R18 and EtBr fluo- 
rescence  was observed  with  a  "Texas  red"  filter  set,  and  HOECHST 
33258 fluorescence under a"DAPI" filter set. 
Spectrofluorometric Measurements 
For measurement of kinetics  of lipid  mixing,  R18  labeled  erythrocytes 
bound to cells as described above were removed from the dish using either 
trypsin-EDTA solution or 50 mM EDTA in PBS at 4°C. The R18-1abeled 
RBC-acceptor cell complexes were washed with cold  PBS and placed on 
ice until further use. Fluorescence changes as a  result of fusion of R18- 
labeled erythrocytes with acceptor cells  were measured continuously us- 
ing a spectrofluorimeter (Alpha Scan, Photon Research Inc., South Bruns- 
wick, N  J) with 1 s time resolution at 560/590 nm excitation and emission, 
respectively.  A  570-nm  cut off filter was placed  in  the emission optical 
pathway to reduce scattering.  50 gl of the R18-1abeled  RBC and acceptor 
cell suspension was placed into a cuvette containing 3 ml PBS prewarmed 
to 37°C.  To  normalize the  data,  percent fluorescence dequenching (% 
FDQ) at any time point was calculated  according to the following  equa- 
tion:  % FDQ =  100. (F-FdFt-F~  0 where Fcl and F are the fluorescence in- 
tensities at time 0 and at a given time point. Ft is the fluorescence intensity 
in the presence of 0.1%  Triton X-100 and defined as fluorescence at "infi- 
nite" dilution of the probe (Bagai et al., 1993). 
Content Mixing Assay 
The content mixing assay based on the cytoplasmic activation of the re- 
porter gene 13-galactosidase was performed essentially as described (Nuss- 
baum et al., 1994) with slight modifications. The cells expressing viral en- 
velope  proteins at  5  h  posttransfection were trypsinized,  suspended in 
DMEM containing 2.5%  NU serum IV to a density of 2 X 10S/ml, and in- 
cubated overnight at 32°C in a  near horizontal position. The cells  were 
washed twice in OPTI-MEM (containing 2.5 mM CaCI2), suspended to a 
density of 2 x  107/ml, and treated with neuraminidase (50 mU/ml) for I h 
at 37°C. The ceils were then washed and suspended in OPTI-MEM at 106 
cells/ml.  A second population of CV-1 ceils was infected with wt vaccinia 
virus  (strain  WR)  for  45  rain  at  37°C  and  transfected  with  plasmid 
pGINT7 [3-gal. At 5 h posttransfection, cells were washed and incubated 
overnight as described above. The cells  were washed with OPTI-MEM. 
The two cell populations were mixed in triplicate  by adding 100 ~1 of each 
cell population in a 96-well tissue culture plate. The plates were incubated 
at 37°C for 4 h. Cell fusion was measured at the indicated times by using a 
colorimetric  lysate  assay  for  13-galaetosidase  as  described  previously 
(Nussbaum et al., 1994). The quantity of [3-galactosidase was calculated  by 
comparing the rates of hydrolysis for each sample with that obtained for a 
standard preparation of E. coil  13-galactosidase (Boehringer Mannheim) 
and was expressed as ng/well. The in situ assay involving X-gal staining of 
cells was done as described previously (Nussbaum et al., 1994). 
Results 
Construction and Expression ofF Protein 
COOH-Terminal Truncation Mutants 
The  transmembrane  domain  of a  type  I  integral  mem- 
brane protein is defined  as the  carboxyl-terminal hydro- 
phobic domain, usually bounded by two charged residues, 
which acts during synthesis to stop the transfer of the na- 
scent polypeptide chain  across the bilayer and brings its 
stable  integration  in  the  membrane.  In  the  case  of the 
paramyxovirus SV5 F  protein, computer-assisted analysis 
of the  hydrophobieity of the F  protein  suggests that  the 
transmembrane domain begins at F residue 485 after a se- 
ries  of serine  and  threonine  residues  and  ends  before a 
lysine residue at F residue 510, yielding a 25-residue trans- 
membrane domain. Thus, the cytoplasmic tail is presumed 
to consist of 20 COOH-terminal residues. To examine the 
role of the paramyxovirus SV5 F  protein cytoplasmic tail 
in membrane fusion, translational stop codons were intro- 
duced  into  the  cytoplasmic  tail.  Four  deletion  mutants 
were constructed and they were designated A5, A10, A15, 
and A19 and their cytoplasmic tails contained deletions of 
5, 10, 15, and 19 amino acids, respectively (Fig. 1). The A19 
mutant has the entire cytoplasmic tail deleted except for 
one positively charged lysine that immediately follows the 
transmembrane domain and marks the presumptive junc- 
tion of the transmembrane and the cytoplasmic domain. 
The F protein COOH-terminal truncation mutants were 
expressed in HeLa-T4 cells by using the recombinant vac- 
cinia virus-T7 RNA polymerase system. To analyze the ex- 
pression and cleavage of F 0 to F 1 and F2, the cells were la- 
beled with Tran-35S-label for 15 rain and were either lysed 
immediately or incubated  in chase medium for 3 h.  Pro- 
teins were immunoprecipitated and polypeptides were an- 
alyzed by SDS-PAGE. As shown in Fig. 2 A, all the pro- 
teins  were  expressed  and  a  significant  fraction  of the  F 
proteins was cleaved to Ft and F 2 after a 3-h chase period. 
In the case of mutant A19, only a weak band correspond- 
ing to F1 polypeptide could be identified but a diffuse band 
of higher mobility than that expected for F I was also ob- 
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terminal truncation mutants. The amino acid sequence of the res- 
idues around the presumptive SV5 wt F protein transmembrane 
domain are shown. As a working hypothesis it is assumed that the 
demarcation between the transmembrane domain and the cyto- 
plasmic tail is between residues 509 and 510. Arrows indicate the 
positions where the premature translational stop codons were in- 
troduced to shorten the COOH-terminal region of the F protein. 
The  designation  of  the  truncation  mutants  (A5,  A10  etc.)  is 
shown, where A5 represents a mutant for which five amino acids 
from COOH-terminal end had been deleted and so forth. The 
positions of the fusion peptide (FP) and the presumptive trans- 
membrane domain (TM) are shown. 
served.  This  diffuse  band  is  thought  to  be  a  heteroge- 
neously glycosylated form  of F~  as on  treatment  of cells 
with deoxymannojirimycin, an inhibitor of a-mannosidase 
I, a discrete F1 band was observed (data not shown). 
Oligomerization of SV5 F Protein COOH-Terminal 
Truncation Mutants 
We have shown that the F protein forms a homo-oligomer 
shortly after its synthesis in the ER  (Russell et al., 1994) 
and the data is consistent with the formation of a homotri- 
mer,  As some cytoplasmic tail mutants have the propen- 
sity to cause profound alterations to native protein folding 
and oligomerization, and in turn affect intracellular trans- 
port  of the  glycoproteins  (Parks  and  Lamb,  1990;  Rose 
and Bergmann,  1983;  Sergel and Morrison,  1995),  it was 
important to examine the effect of the F  protein cytoplas- 
mic tail mutations on oligomerization and transport prop- 
erties of the protein. To assess the competence of altered F 
proteins to form oligomers (trimers), chemical cross-link- 
ing studies were done. HeLa-T4 cells expressing the trun- 
cation  mutants  were  labeled  with  Tran-35S-label  at  5  h 
posttransfection for 30 rain at 37°C and cultures were incu- 
bated in  chase medium for 2  h  to  allow for  intracellular 
transport  to  the  plasma  membrane.  Cross-linking  reac- 
tions were performed using the homobifunctional reagent 
DTSSP on either intact cells, to react with the cell surface 
F  molecules, or on detergent solubilized (NP-40)  cell ex- 
tracts to render all F  molecules available for cross-linking. 
As  shown  in Fig. 2  B  all the  F  protein  COOH-terminal 
truncation mutants could be cross-linked to homotrimers 
(species 3) both in the presence and absence of the deter- 
gent,  indicating  intracellular  oligomer  formation.  The 
cross-linking pattern  observed  (species  1,  2,  and  3)  was 
found to be consistent with that observed previously when 
cross-linking  studies  were  performed  using  SV5  virus- 
infected cells (Russell et al., 1994). Thus, all the F  protein 
mutants could form oligomers similar to that of the wt F 
Figure  2.  Expression  and  oligomeric  form  of  the  F  protein 
COOH-terminal truncation mutants. (A) To express the altered 
F proteins, HeLa-T4 cells were infected with vaccinia virus vTF7-3 
at 10 pfu per cell for 45  min at 37°C  and then transfected with 
plasmids encoding wt and mutant F proteins as described in Ma- 
terials and Methods. Transfected cells were metabolically  labeled 
with Tran-35S-label (100 txCi/ml) at 5 h posttransfection for 15 min 
and incubated in chase medium for 0 or 3 h. Polypeptides were 
immunoprecipitated with F2-specific antiserum and analyzed by 
SDS-PAGE on 15% gels under reducing conditions. Mock repre- 
sents polypeptides immunoprecipitated from vTF7-3 infected but 
untransfected cells. Radioactivity was detected by fluorography. 
(B)  HeLa-T4  cells  expressing  the  F  protein  COOH-terminal 
truncation mutants were labeled with Tran-35S-label (100 IxCi/ml) 
at 5 h posttransfection for 30 rain and incubated in chase medium 
for 2 h  at 37°C. Cross-linking reactions were performed on cell 
suspensions in the absence (-) or presence (+) of 0.5% NP-40 as 
described in Materials and Methods. F protein species were im- 
munoprecipitated and polypeptides analyzed on a 3.5% gel under 
nonreducing conditions. The three predominant species are indi- 
cated by arrows. 
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not  determine  whether  the  mutant  F  proteins  oligomers 
are as stable as the wt F protein oligomers. 
Analysis of the Rate of lntracellular Transport of the F 
Protein COOH-Terminal Truncation Mutants 
To determine the effect of the COOH-terminal region de- 
letion mutations on transport of F  proteins to the medial- 
Golgi apparatus,  the  rate  of acquisition  of carbohydrate 
chains resistant to endo H  digestion was analyzed. Acqui- 
sition of endo H  resistance is indicative of the conversion 
of carbohydrate  chains  from  the  simple  to  the  complex 
form  in  the  medial-Golgi compartment.  We have  shown 
previously that the two carbohydrate chains on the F2 sub- 
unit remain in the high mannose form and do not acquire 
resistance  to  endo  H  digestion (Bagai and  Lamb,  1995a; 
Horvath and Lamb,  1992).  However, most of the F1  sub- 
unit carbohydrate chains acquire endo H  resistance. 
When the rate of transport to the medial-Golgi appara- 
tus of the wt F  protein expressed using the vaccinia virus- 
T7 system was determined, it was found to acquire endo H 
resistance with a tt/2 ~70-75 min. By 180 min, >90% of the 
F  molecules were transported to the medial-Golgi appara- 
tus (Fig. 3 A). Mutants  A5, A10, A15, and A19 all showed 
rates of loss of carbohydrate chains sensitive to endo H  di- 
gestion that were very similar to that for wt F protein (Fig. 
3  A): quantification  was  done  relative to  the  loss of the 
sensitive form, as the resistant form of A19 was heteroge- 
neous in migration and difficult to quantify. Hence, the de- 
letion in COOH-terminal domain of the F  protein did not 
have a major effect on the rate of transport of the proteins 
to the medial-Golgi apparatus. 
Cleavage of F 0 to Ft and F2 occurs during its transit from 
Figure 3.  Kinetics of intracellular transport of F protein COOH-terminal truncation mutants to the medial-Golgi apparatus and the 
cleavage compartment. (,4) HeLa-T4 cells expressing the F protein COOH-terminal truncation mutants were labeled with Tran-35S- 
label (100 ixCi/ml) at 5 h posttransfection for 15 min and incubated in chase medium for the times indicated. Polypeptides were immuno- 
precipitated with F2-specific  antiserum and incubated with (+) or without (-) endo H and analyzed by SDS-PAGE on a 10% gel under 
nonreducing conditions. (i) wt; (ii) mutant A15; F, indicates mobility of both disulfide linked heterodimer of Ft +F2 and F0; Fs, endo H 
sensitive form of F; FR, endo H-resistant form of F. (iii) Quantification by densitometric analysis of autoradiograms. Due to the pres- 
ence of multiple endo H-resistant forms in mutant A19, it was difficult to quantify the endo H-resistant species, hence for all the mu- 
tants, data are plotted as the percentage of remaining endo H-sensitive species. (B) HeLa-T4 cells expressing the F protein COOH-ter- 
minal truncation mutants were labeled with Tran-35S-label (100 IxCi/ml) for 15 rain at 5 h posttransfection and incubated in the chase 
medium for the times indicated. Polypeptides were immunoprecipitated with F2-specific antiserum and analyzed by SDS-PAGE on a 
15% gel under reducing conditions. (i) wt; (ii) mutant A15; (iii) rates of cleavage of F0 to Fl and F2. Autoradiograms were quantified by 
densitometric analysis. Data are plotted as the percent of total F-specific species remaining as F0. 
Bagai and Lamb  Hemificsion  and Complete Fusion  77 the trans-Golgi apparatus (Klenk and Garten, 1994; Morri- 
son et al., 1985).  To determine the rate of transport of the 
mutant F proteins to the cleavage compartment, HeLa-T4 
cells expressing the mutant F proteins at 5 h posttransfec- 
tion were metabolically labeled with Tran35S-label for 15 
min, the cultures incubated in the chase medium for vari- 
ous time periods and the F  polypeptides immunoprecipi- 
tated and the F0, F1 and F2 polypeptides were analyzed by 
SDS-PAGE. The amount of F0, as a percentage of total F 
polypeptide  species  was  determined  by  densitometric 
scanning of autoradiographs (Fig. 3 B). The rate of cleav- 
age for all the mutants was found to be similar to that of wt 
F protein; however, the final extent of cleavage was some- 
what lower for mutant  A15 as compared to that of wt F 
protein. For both wt F  protein and the mutants, cleavage 
did not reach completion even after 180 min of chase pe- 
riod  and  only  50%  of the  molecules  were  found  to  be 
cleaved in 3 h. This finding is consistent with our earlier 
studies using the vaccinia virus transient expression system 
(Bagai and Lamb, 1995a), whereas in SV5  virus-infected 
cells cleavage of F goes to completion in 3 h (Horvath and 
Lamb, 1992). It is thought that the high level expression of 
F protein using the vac-T7 expression system saturates the 
amount of available cleavage enzyme, furin, present in the 
TGN (Klenk and Garten, 1994).  Nonetheless, the rate and 
extent of cleavage was very similar for all the mutants and, 
as will be shown below, sufficient active F proteins are ex- 
pressed to readily measure fusion activity. 
Surface Expression of the F Protein COOH-Terminal 
Truncation Mutants 
The cell surface expression of the altered F  proteins was 
quantified by flow cytometry. Cells were stained with F-spe- 
cific mAb, Fla. As shown in Table I, all the mutants showed 
both a comparable percentage of positive cells as compared 
to wt F  protein and exhibited  a similar mean fluorescent 
intensity (MFI) except for mutant A15 which had a some- 
what  reduced  MFI,  a  finding  which  correlates  with  its 
somewhat reduced rate of cleavage (Fig. 3 B). 
Induction of Cell Fusion by the F Protein 
COOH-Terminal Truncation Mutants 
Cell fusion involves both the mixing of the  outer leaflet 
membrane  lipids  and  the  mixing  of inner  leaflet  mem- 
brane lipids with concomitant mixing of aqueous contents 
of donor  and  recipient  cells  (Kemble  et  al.,  1994).  We 
therefore determined the ability of CV-1 cells expressing 
Table L Surface Expression ofF Proteins 
Mean fluorescent 
Protein  Positive cells*  intensity "~ 
% 
Wt F  22.9  1.0 
FA5  24.4  0.75 
FA 10  22.6  0.73 
FAI5  18.4  0.58 
FA 19  28.2  0.88 
* Determined by flow cytometry. 
:!:Mean fluorescent  intensity  (MFI) was derived from flow cytometry data and is ex- 
pressed as the amount compared to the value for wt F protein. 
the  wt F  or COOH-terminal truncation  mutants  to fuse 
with target red blood cells (RBCs) prelabeled with fluo- 
rescent lipid and fluorescent soluble content probes either 
singly or in combination. 
Lipid mixing activity of F protein COOH-terminal trunca- 
tion mutants: Kinetics. To  obtain  information  about  the 
rates and extents of wt F or mutant F protein induced fu- 
sion, we measured the kinetics of fluorescence dequench- 
ing of the lipophilic probe R18. The lipid probe R18 was 
incorporated into RBCs which were then mixed with the 
acceptor cells expressing the wt F  or the COOH-terminal 
truncation mutants.  As this assay is done in suspension, 
the F  protein expressed alone yields no fluorescence de- 
quenching on mixing with R18 labeled erythrocytes (Bagai 
and Lamb, 1995b) because the binding of one cell to an- 
other requires either the paramyxovirus sialic acid binding 
glycoprotein HN or the influenza virus sialic acid-binding 
protein  HA.  As  shown  in  Fig.  4,  wt  F  protein  and  the 
COOH-terminal truncation mutant F proteins coexpressed 
with HN mediated rapid and efficient lipid mixing. The ki- 
netics of fluorescence dequenching was comparable for wt 
F  protein and all the truncation  mutants. The F  protein- 
mediated fusion was inhibited by preincubation of R18 la- 
beled RBC-acceptor cell suspensions with  a  monoclonal 
antibody  specific  to  SV5  F  protein,  strongly  suggesting 
that the fluorescence dequenching observed on coexpres- 
sion of F  and HN is due to the specific fusion activity of 
the F protein and is not an artifact as a result of nonspe- 
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Figure 4.  Kinetics of fusion of R18 labeled RBCs with cells ex- 
pressing wt F or COOH-terminal truncation mutants. R18 labeled 
RBCs were bound to CV-1 cells expressing wt F and the F pro- 
tein  COOH-terminal truncation  mutants  and  the  fluorescence 
measurements were  performed as  described  in  Materials  and 
Methods. Trace A, B, C, D, and E represents fusion of cells coex- 
pressing SV5 HN protein and wt F, A5, At0,  A15, and A19, re- 
spectively, with labeled RBCs. Trace F and G represents fusion 
of labeled RBCs with cells coexpressing influenza virus HA pro- 
tein and wt F and 2x19, respectively. All other mutants also exhib- 
ited similar kinetics on coexpression  with HA (data not shown). 
Trace H represents fusion of cells expressing F and HN proteins 
in the presence of the F-specific monoclonal antibody F1 a. 
The Journal of Cell Biology, Volume 135,  1996  78 cific  dye  transfer.  Lipid  mixing  activity  was  also  deter- 
mined  when  the  F  proteins  were  coexpressed  with  HA. 
Significant  fluorescence  dequenching  was  observed  and 
again the kinetics of fusion was similar for all the F protein 
COOH-terminal  truncation mutants and the wt F  protein 
when the F  proteins were coexpressed with influenza HA. 
However, the rates  as  well  as  the  extents  of lipid  mixing 
were found to be lower with the heterotypic-binding pro- 
tein, confirming our earlier data (Bagai and Lamb, 1995b). 
Hence,  the lipid mixing activity of the F  protein COOH- 
terminal  truncation  mutants  appears  in  all  aspects  to  be 
the same as wt F protein. 
Content mixing activity of the F protein  COOH-terminal 
truncation mutants. We employed the reporter gene ([3-galac- 
tosidase) activation assay (see Materials and Methods) to 
measure  the  content  mixing  potential  of  the  F  protein 
Figure  5.  Reporter  gene  activation  assay 
(content  mixing)  for  the  F  protein  COOH- 
terminal truncation  mutants.  One culture of 
CV-1 cells was infected with recombinant vac- 
cinia virus vacTF7-3, which encodes T7 RNA 
polymerase, and  cotransfected  with  plasmid 
DNA encoding the cDNAs for the SV5 HN 
and  wt  F  or the  F  protein  COOH-terrninal 
truncation  mutant  proteins.  Cells were then 
treated  with  bacterial  neuraminidase  as  de- 
scribed in Materials and Methods. A  second 
culture  of  CV-1 cells  was  infected  with  wt 
vaccinia  virus  (strain  WR)  and  transfected 
with  plasmid  pGINT713-gal  which  encodes 
[3-galactosidase.  The  cell  populations  were 
washed  and  suspended  in  OPTI-MEM  con- 
taining CaC12 (2.5  mM)  at  106 per ml.  Mix- 
tures of the two populations of cells (0.1 ml 
each)  were  plated  in  triplicate  in  96-well 
plates and incubated at 37°C. (Top) After in- 
cubation at 37°C for 4 h,  samples were ana- 
lyzed by using in situ X-gal staining (Materi- 
als  and  Methods).  Cells were photographed 
using  a  Kodak  Digital  420  camera  at  10  x 
magnification on a Nikon inverted phase con- 
trast microscope. (Bottom) Samples were an- 
alyzed by the colorimetric lysate assay as de- 
scribed in Materials and Methods. Each point 
represents an average of three experiments _ 
SD. BWT represents mutant A19 that was re- 
verted back  to wt  as  described in  Materials 
and Methods. 
Bagai and Lamb Hemifusion and Complete Fusion  79 COOH-terminal truncation mutants. The [3-galactosidase 
activity was analyzed by in situ X-Gal staining assay (Fig. 
5, top) and by a quantitative colorimetric assay for 13-galac- 
tosidase activity (Fig.  5, bottom). In contrast to the data 
obtained  for lipid mixing, the  content  mixing activity of 
the  F  protein  COOH-terminal  truncation  mutants  was 
found to decrease in parallel with the extent of the dele- 
tion of the F protein cytoplasmic tail (Fig. 5). The reduced 
content mixing activity observed with mutant A15 could be 
due to its lower surface expression level (Table I) but we 
do not believe this is the case as the lower expression level 
of A15 did not affect the rate or extent of lipid mixing ac- 
tivity. The most striking effect of the COOH-terminal de- 
letions on content mixing was observed with mutant A19 
where  the  level of 13-galactosidase  activity detected  was 
similar to background levels observed when mock-infected 
cells were used in the assay. 
To confirm that the complete loss in the content mixing 
activity in mutant A19 was a result of deletion of the F pro- 
tein  COOH-terminal  and  not  due  to  another  mutation 
that  might have  been  inadvertently  introduced  in  the  F 
gene  during  mutagenesis,  the  back  mutant  (BWT)  was 
made in which the translational stop codon was converted 
to leucine. As shown in Fig. 5, the content mixing activity 
was found to be completely restored in BWT confirming 
that the loss of the content mixing activity in mutant A19 is 
due to the lack of the F protein COOH-terminal domain. 
To determine whether the presence of the heterogenous 
carbohydrate chains on the FI subunit of mutant A19 con- 
tributed  to  loss  of  content  mixing  activity,  cells  were 
treated with DMJ during expression of wt F  protein and 
mutant A19  and during  the content mixing assay. It was 
found that the content mixing activity of wt F protein was 
unaffected  by DMJ  treatment,  and  that  treatment  with 
DMJ did not restore detectable content mixing activity to 
mutant A19. Thus, taken together these findings indicate 
that, in contrast to the lipid mixing results, the removal of 
the  COOH-terminal  domain  completely  abolishes  the 
content mixing activity. 
Microscopy: Lipid dye  but not aqueous dye spreads  be- 
tween RBCs and mutant A19 expressing cells under fuso- 
genic conditions. To eliminate the possibility that the lipid 
mixing data and the content  mixing data were reflecting 
properties  of two  subpopulations  of F  expressing  cells, 
rather than being a property of the same cell, we used fluo- 
rescence microscopy. The F proteins with the most varied 
fusion promoting activity, wt F  protein and mutant A19, 
were used for these experiments. First, we wished to show 
that the lipophilic probe R18, on fusion of the R18-1abeled 
RBCs to F  protein expressing cells was restricted  to the 
lipid bilayer. As shown in Fig. 6, cells expressing wt F and 
mutant A19 proteins showed intense fluorescent staining 
of the lipid bilayer. For double-labeling of RBCs the dye 
NBD-taurine was trapped into the aqueous interiors and 
the  lipid  dye  R18  was  incorporated  into  the  cell  mem- 
branes. The colabeled RBCs were bound to wt F and mu- 
tant A19 expressing cells at 4°C.  After incubation at 37°C, 
the cells were observed by fluorescence microscopy. The 
colabeled RBCs transferred R18 to both wt F and A19 ex- 
pressing  cells  under  fusogenic conditions  (Fig.  7).  How- 
ever, only the  wt F  protein  expressing cells took up the 
aqueous  dye  NBD-taurine.  Mutant  A19  expressing  cells 
bound to RBCs became labeled with the lipid probe R18 
but  no  cells  became  labeled  with  the  aqueous  content 
probe. Control cells maintained at 4°C did not take up any 
of the dyes. Hence, even though mutant A19 can promote 
efficient transfer of outer leaflet lipids, it failed to promote 
transfer of cytoplasmic contents. 
It has been shown recently that ability to detect small 
and/or transient fusion pores between RBCs and cells can 
be improved by loading RBCs with  1 mM ethidium bro- 
mide (EtBr) (mol wt 394) (Melikyan et al., 1995).  Human 
RBCs  do  not  contain  a  nucleus  and  are  not  stained 
strongly by EtBr. Upon fusion with cells containing a nu- 
cleus, EtBr intercalates  into target cell DNA,  leading to 
both a major increase in fluorescence quantum yield and 
irreversible accumulation in the cell nucleus.  Thus, in an 
attempt to detect if small pore formation occurs with mu- 
tant A19 that could not be detected using NBD-taurine, we 
loaded  RBCs  with  EtBr.  Under  fusogenic  conditions, 
none of the cells expressing mutant A19 were stained with 
EtBr (Fig. 7). However, many of the wt F expressing cells 
were found to be stained with EtBr (Fig. 7). Very similar data 
were  obtained  using  the  DNA staining  dye HOECHST 
33258 (data not shown). Thus, the wt F protein expressing 
cells exhibited aqueous continuity with RBCs under fuso- 
genic conditions whereas mutant A19 expressing cells did 
not, indicating that the presence of the F protein COOH- 
terminal domain is necessary for content mixing to occur. 
Discussion 
The  data  presented  here  indicate  that  progressive dele- 
tions in the COOH-terminal region of the SV5 F protein, 
causes an increasingly deleterious effect on the ability of 
the altered F  proteins to mediate the final step in fusion, 
content mixing, whereas there is no discernable effect on 
the presumptive early step in fusion, hemifusion. Opera- 
tionally, the  transmembrane domain  of a  type I  integral 
membrane protein is defined  as a  COOH terminally lo- 
cated hydrophobic region of ~20-30 residues that is usu- 
ally bounded by two charged residues. In the case of the 
SV5 F protein, a computer-assisted analysis of the hydro- 
phobicity of the COOH-terminal region suggests that the 
transmembrane domain is residues 485-510,  which would 
yield a 20-residue cytoplasmic tail. However, the residues 
assigned to  the  transmembrane domain  form a  working 
hypothesis,  especially as  on  the  ectodomain  side  of the 
transmembrane domain there is not a charged residue un- 
til  residue  471.  Furthermore,  some  transmembrane  do- 
mains are known to tolerate  a  charged residue  and thus 
lysine residue 510 and the residues up to arginine residue 
519 could form part of the transmembrane domain and if 
this is the case the F  protein would only have a cytoplas- 
mic tail of 11 residues. 
The effect of the F protein truncation mutations on cy- 
toplasmic content mixing was not secondary to a major de- 
fect in protein oligomerization, rate of intracellular trans- 
port, or cell surface expression level. Mutant A19 showed 
more heterogeneous carbohydrate modifications than wt 
F protein and this carbohydrate modification could be pre- 
vented by synthesis of A19 F  protein in the  presence of 
deoxymannojirimycin (DMJ), an inhibitor of et-mannosi- 
dase I. When A19 was synthesized in the presence of DMJ 
The Journal of Cell Biology, Volume 135,  1996  80 Figure 6.  Lipid mixing with cells expressing wt F or mutant A19 F protein. RBCs labeled with only R18 were bound to CV-1 cells coex- 
pressing SV5 HN and either wt F or mutant A19 F protein and fusion was triggered by shifting incubation to 37°C. After 10 min incuba- 
tion at 37°C, the distribution of dye was monitored microscopically. 
Figure 7.  Lipid and aqueous content dye mixing with cells expressing wt F protein or truncation mutant A19 F protein. RBCs colabeled 
with R18 and NBD-taurine or labeled singly with EtBr were bound to CV-1 cells coexpressing SV5 HN and either wt F protein or F  A19 
COOH-terminal truncation mutant protein and fusion was triggered by shifting incubation to 37°C. After 30 min incubation at 37°C, dye 
transfer from RBCs to cells was visualized in a fluorescent microscope using appropriate filters as described in Materials and Methods. 
Control panel shows the cells coexpressing SV5 HN and either wt F  protein or the mutant A19 F  protein bound to labeled RBCs and 
maintained at 4°C. 
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carbohydrate modifications did not influence fusion activ- 
ity. The reason that A19 F carbohydrate chains are modi- 
fied differently from wt F protein is unknown but it is in- 
teresting  to  note  that  GPI-linked  HA,  unlike  wt  HA,  is 
also  modified  by  heterogenous  carbohydrate  extensions 
(Kemble et al., 1993, 1994). 
Alterations  to  the  cytoplasmic  tails  of  viral  glycopro- 
teins have varying effects on properties of the proteins. In 
some cases deletions or changes in the sequence of the cy- 
toplasmic tail delay or inhibit intracellular transport of the 
proteins, e.g., paramyxovirus HN and VSV G protein (Parks 
and  Lamb,  1990;  Rose  and  Bergmann,  1983).  In  other 
cases deletion or changes in the sequence of the cytoplas- 
mic tail have little effect on intracellular transport of the 
proteins, e.g., Semliki Forest virus E2 glycoprotein, influ- 
enza  virus  HA,  Rous  sarcoma  virus  env  glycoprotein, 
Friend murine leukemia virus  env glycoprotein  (Garoff 
et al., 1983; Jin et al., 1996;  Kilpatrick et al., 1987;  Perez 
et al., 1987; Simpson and Lamb, 1992).  For human immu- 
nodeficiency virus and simian immunodeficiency virus env 
glycoproteins deletion of the cytoplasmic tail does not af- 
fect  intracellular  transport  but,  by  an  unknown  mecha- 
nism, it increases syncytia formation (Mulligan et al., 1992; 
Ritter et al., 1993). Even among paramyxovirus F protein, 
changes in the cytoplasmic tail have varying effects on in- 
tracellular transport (Sergel and Morrison, 1995; Yao and 
Compans,  1995).  Deletion  of  the  presumed  cytoplasmic 
tail of the SV5 F protein has little effect on its intraceliular 
transport, thus permitting determination  of effects on fu- 
sion activity. 
The mechanism by which the paramyxovirus F  protein 
mediates fusion is not understood.  It seems unlikely that 
the F  protein  hydrophobic fusion  peptides  are freely ex- 
posed  to  an  aqueous  environment  after  cleavage-activa- 
tion  (either in the trans-Golgi network or at the cell sur- 
face) as aggregation of the F protein oligomers would most 
likely occur. Thus, by analogy to influenza virus HA, it has 
been hypothesized that the cleaved F protein undergoes a 
conformational change to expose the fusion peptide at the 
right time and in the right place (Lamb, 1993; Sergel et al., 
1993). For influenza virus HA the metastable cleaved neu- 
tral pH form of HA undergoes a low pH-induced confor- 
mational change to expose the buried fusion peptide (Ske- 
hel et al., 1982). From the X-ray structure of a proteolytic 
fragment of the low pH-induced form of HA, it is known 
that  two  out-of-register  c~-helical  regions  rearrange  and 
form a triple stranded coiled-coil 105 A  in length, with the 
fusion  peptide  at  the  extremity  of  the  coiled-coil  (Bul- 
lough et al., 1994). Several studies have suggested that the 
paramyxovirus F  fusion  peptide  forms  an o~  helix  (Bras- 
seur et al., 1988; Hsu et al., 1981) and this putative a-heli- 
cal domain is followed  in the F1 protein  sequence  by an 
out-of-register 42 residue heptad repeat (Chambers et al., 
1990; Lamb,  1993).  Thus,  by  analogy  to  influenza  virus 
HA, it has been suggested that paramyxovirus F proteins 
may undergo  a  conformational  change  to form a  related 
coiled-coil  structure  (Carr  and  Kim,  1993;  Lamb,  1993). 
However, unlike influenza virus where the biologically rel- 
evant trigger to the conformational change is low pH, the 
trigger  for  the  proposed  paramyxovirus  conformational 
change has not been identified. 
Hemifusion  is a presumptive intermediate  event in the 
fusion process, in which the outer but not the inner leaflets 
of two fusing membranes have merged but there is no mix- 
ing of their  aqueous  contents.  Ultrastructural  studies  on 
the steps of fusion  of biomembranes  have indicated  that 
an intermediate single bilayer occurs but such intermedi- 
ates  are  very  transitory  structures:  e.g.,  in  exocytosis  of 
vascular  endothelial  vesicles  (Palade  and  Bruns,  1968; 
Palade,  1975),  zoospore  secretion  in Phytophythora pal- 
mivora (Pinto da Silva and Nogueira, 1977), myoblast fusion 
(Kalderon and Gilula, 1979), and the fusion of carrot pro- 
toplasts  by  poly  (ethylene  glycol)  (Kanchanapoom  and 
Boss, 1986). Other work using fluorescent probes to study 
the fusion of phospholipid vesicles has also shown that un- 
der certain conditions,  an intermixing of lipid probes can 
occur without  mixing of the  vesicular  contents  (Cherno- 
mordik et al., 1995; Ellens et al., 1985; Fischer and Parker, 
1984; Helm et al.,  1989,  1992; Horn,  1984; Leventis et al., 
1986; Neher, 1974).  Such hemifused bilayer intermediates 
have  been  observed  as  stable  states  during the  fusion  of 
planar phospholipid bilayers in model membrane systems. 
Hemifusion  has also been detected  during artificially in- 
duced fusion between biological membranes such as dur- 
ing electrically induced fusion of RBCs (Song et al., 1991; 
Stenger and Hui, 1986) and PEG induced fusion of human 
erythrocytes (Ahkong et al., 1987). However, the only evi- 
dence for hemifusion in a well-characterized protein-medi- 
ated fusion system obtained to date is with a modified form 
of the influenza HA protein in which the transmembrane 
domain was substituted for a GPI anchor (Kemble et al., 
1994). Our studies with the SV5 F  tail truncation mutant 
A19  have  demonstrated  hemifusion  with  another  fusion 
protein. For HA, removal of the cytoplasmic tail does not 
affect formation of the fusion pore or content mixing (Jin 
et al., 1996). However, as discussed above, removal of the 
HA transmembrane domain and replacement with a GPI- 
anchor abolishes pore formation (Kemble et al., 1994; Me- 
likyan et al., 1995). 
For influenza  HA,  it has been suggested that  separate 
domains of HA may control individual steps in fusion and 
an elastic coupling model has been proposed (Melikyan et 
al., 1995). A mechanical coupling between the ectodomain 
and the transmembrane domain of HA is hypothesized to 
be responsible  for pore formation  within  the hemifusion 
diaphragm  and  it is  suggested  that  the  hydrophilic  cyto- 
plasmic tail may also help in destabilizing the diaphragm 
that  separates  aqueous  contents  (Melikyan  et  al.,  1995). 
We assume that HA and SV5 F protein mediate fusion by 
similar mechanisms. However, because of the difficulty in 
defining  precisely the  residues  that constitute  the  SV5  F 
protein cytoplasmic tail, it cannot be determined if the HA 
and F  protein  cytoplasmic tails have  differing  effects  on 
the final fusion event. If the SV5 F protein cytoplasmic tail 
consists of 20 residues,  it is possible  that the cytoplasmic 
tail is needed  to maintain the transmembrane  domain  in 
an  appropriate  conformation  which  facilitates  formation 
of the  fusion  pore but this interaction between  the  cyto- 
plasmic  tail  and  transmembrane  domain  is  not  required 
for HA mediated fusion. It is also possible that the hypoth- 
esized  role  of  the  cytoplasmic  tail  in  destabilizing  the 
hemifusion  diaphragm is  more  critical  in  SV5  F  protein- 
induced fusion. However, if the SV5 F protein cytoplasmic 
The Journal of Cell Biology, Volume 135, 1996  82 tail only consists of 11 residues then removal of a part of 
the transmembrane  domain in mutant A19,  may directly 
affect fusion pore formation. 
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